Pennsylvania HB 2719: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Status: PN 4280 Referred to JUDICIARY (as of 2018-10-17)

State: Pennsylvania · Session: 2017-2018 · Bill: HB 2719

Sponsors: Comitta, Daley, Hill-Evans, J. Mcneill, Rozzi, Schlossberg, Youngblood

View Pennsylvania HB 2719 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.